Atlas Trials

A Phase 2 Study of SSGJ-707 in Metastatic Colorectal Cancer Patients

Clinical trial NCT06493760 · RECRUITING

Trial details

NCT number
NCT06493760
Sponsor
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Colorectal Cancer
Start date
2024-09-03
Primary completion
2025-06-01
Enrollment
130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.